Study on the stability of Procaterol Hydrochloride Oral Solution 盐酸丙卡特罗口服溶液工艺的研究
Procaterol in treatment of upper respiratory tract infections in 324 patients 丙卡特罗对症治疗急性上呼吸道感染324例
Conclusion Using different mixing liquid tank and container can decrease the content of Procaterol Hydrochloride Oral Solution. 结论配液罐和容器的选用对盐酸丙卡特罗口服溶液稳定性的影响大。
At the same time, the linear plots of separation factor to mobile phase polarity of clenbuterol and procaterol enantiomers were found. 同时,对四种选择性β2受体兴奋药物在Whelk-O1等四种手性固定相上的拆分实验表明,流动相极性对分离因子的影响基本成线性。
CONCLUSION: The effective time of procaterol was 12 h. 结论:丙卡特罗作用时间可达12h。
CONCL USION: Procaterol aerosol inhaler was effective and safe in mild and moderate bronchial asthma treatment. 结论:丙卡特罗气雾剂治疗轻中度支气管哮喘是有效而且安全的。
A Multicenter Randomized Controlled Clinical Trial of Procaterol Aerosol Inhaler Versus Salbutamol Aerosol Inhaler in Asthma Treatment 丙卡特罗气雾剂与喘乐宁气雾剂治疗支气管哮喘随机对照多中心临床试验
Bronchodilator time of procaterol 丙卡特罗扩张支气管的作用时间
The test group was treated with procaterol hydrochloride and budesonide dry-powder inhalant, the control group was treated with procaterol hydrochloride placebo and budesonide dry-powder inhalant. They all were continuously treated for 8 weeks. 其中,试验组给予盐酸丙卡特罗加布地奈德粉吸入剂,对照组给予盐酸丙卡特罗安慰剂加布地奈德粉吸入剂,共治疗8周。
Procaterol Hydrochloride can decreased the AHR caused by Substance P, which is an effective pathway to treat asthma. 盐酸丙卡特罗可降低因气道内滴入P物质引起的气道高反应性,是其治疗哮喘的一个有效途径。